Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Klok, F.A., Kruip, M.J.H.A., van der Meer, N.J.M., Arbous, M.S., Gommers, D.A.M.P.J., Kant, K.M., Kaptein, F.H.J., van Paassen, J. +3 more·2020·Thrombosis Research
DOI 10.1016/j.thromres.2020.04.013

Cited by (1,012)

Items 901–1,000 of 1,012

  1. Pathogenesis and Management of Myocardial Injury in Coronavirus Disease 2019
    Zhiyao Wei, Yong‐Jian Geng, Ji Huang, Hai‐Yan Qian · 2020 · European Journal of Heart Failure
  2. Incidence and Outcomes of Thrombotic Events in Symptomatic Patients With COVID-19
    Ayman Elbadawi, Islam Y. Elgendy, Aditya Sahai, Rohan Bhandari, Meghann McCarthy, Marcelo P. Villa-Forte Gomes, G. Jay Bishop, John R. Bartholomew, Samir Ramesh Kapadia, Scott J. Cameron · 2020 · Arteriosclerosis Thrombosis and Vascular Biology
  3. Coagulation Disorders in COVID-19: Role of Toll-like Receptors
    Indranil Biswas, Gausal Azam Khan · 2020 · Journal of Inflammation Research
  4. Efficacy, Safety and Future Perspectives of JAK Inhibitors in the IBD Treatment
    Patrycja Dudek, Adam Fabisiak, Hubert Zatorski, Ewa Malecka-Wojciesko, Renata Talar‐Wojnarowska · 2021 · Journal of Clinical Medicine
  5. Characteristics and mortality of 561,379 hospitalized COVID-19 patients in Germany until December 2021 based on real-life data
    Jan Andreas Kloka, Lea Valeska Blum, Oliver Old, Kai D. Zacharowski, Benjamin Friedrichson · 2022 · Scientific Reports
  6. Rare presentations of COVID-19: PRES-like leukoencephalopathy and carotid thrombosis
    Florence Xini Doo, Gassan Kassim, Daniel R. Lefton, Shanna Patterson, Hien Pham, Puneet B. Belani · 2020 · Clinical Imaging
  7. Pulmonary Thrombosis or Embolism in a Large Cohort of Hospitalized Patients With Covid-19
    Natividad Benito, David Filella, José Mateo, Ana Mª Fortuna, Juan E. Gutierrez-Alliende, Nerea Hernandez, Ana Giménez, Virginia Pomar, Ivan Castellvi, Hèctor Corominas et al. · 2020 · Frontiers in Medicine
  8. Montelukast Drug May Improve COVID-19 Prognosis: A Review of Evidence
    Jean Barré, Jean‐Marc Sabatier, Cédric Annweiler · 2020 · Frontiers in Pharmacology
  9. Myocardial Injury in Severe COVID-19 is Similar to Pneumonias of Other Origin: Results from a Multicentre Study
    Peter Jirak, Robert K. Larbig, Zornitsa Shomanova, Elisabeth Fröb, Daniel Dankl, Christian Torgersen, Nino Frank, Magdalena Mahringer, Dominyka Butkiene, Hendrik Haake et al. · 2020 · ESC Heart Failure
  10. Incidence and characterization of acute pulmonary embolism in patients with SARS-CoV-2 pneumonia: A multicenter Italian experience
    Marco Loffi, Valentina Regazzoni, Marco Toselli, Alberto Francesco Cereda, Anna Palmisano, Davide Vignale, Francesco Moroni, Gianluca Pontone, Daniele Andreini, Maria Elisabetta Mancini et al. · 2021 · PLoS ONE
  11. Targeting MMP-Regulation of Inflammation to Increase Metabolic Tolerance to COVID-19 Pathologies: A Hypothesis
    Eugenio Hardy, Carlos Fernández-Patrón · 2021 · Biomolecules
  12. Seroconversion and fever are dose-dependent in a nonhuman primate model of inhalational COVID-19
    Paul A. Dabisch, Jennifer Biryukov, Katie Beck, Jeremy A. Boydston, Jaleal S. Sanjak, Artemas Herzog, Brian Green, Gregory Williams, John J. Yeager, J. Kyle Bohannon et al. · 2021 · PLoS Pathogens
  13. Emerging Infectious Diseases Are Virulent Viruses—Are We Prepared? An Overview
    Jasmine J. Han, Hannah Song, Sarah L. Pierson, Jane Shen-Gunther, Qingqing Xia · 2023 · Microorganisms
  14. Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications
    MA Haimei · 2020 · Clinical and Applied Thrombosis/Hemostasis
  15. The original and modified Caprini score equally predicts venous thromboembolism in COVID-19 patients
    Sergey Tsaplin, Ilya Schastlivtsev, Sergey Zhuravlev, Victor Barinov, Kirill Victorovich Lobastov, Joseph A. Caprini · 2021 · Journal of Vascular Surgery Venous and Lymphatic Disorders
  16. Pathophysiology of Antiphospholipid Syndrome
    David Green · 2021 · Thrombosis and Haemostasis
  17. Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy
    Kamal S. Saini, Carlo Lanza, Marco Romano, Evandro de Azambuja, Javier Cortés, Begoña de las Heras, Javier de Castro, Monika Lamba Saini, Sibylle Loibl, Giuseppe Curigliano et al. · 2020 · British Journal of Cancer
  18. COVID-19 and Microvascular Disease: Pathophysiology of SARS-CoV-2 Infection With Focus on the Renin-Angiotensin System
    Daniel Arthur Barata Kasal, Andrea De Lorenzo, Eduardo Vera Tibiriçá · 2020 · Heart Lung and Circulation
  19. Heart, COVID‐19, and echocardiography
    Lidia Capotosto, Bich Lien Nguyen, Maria Rosa Ciardi, Claudio Maria Mastroianni, Antonio Vitarelli · 2020 · Echocardiography
  20. Eculizumab treatment for renal failure in a pediatric patient with COVID-19
    Ruchi Gupta Mahajan, Marissa Lipton, Larisa A. Broglie, Namrata Gargee Jain, Natalie Uy · 2020 · Journal of Nephrology
  21. Hyperthrombotic Milieu in COVID-19 Patients
    Mohamed Hassan Kamel, Wenqing Yin, Chris Zavaro, Jean M. Francis, Vipul Chimanlal Chitalia · 2020 · Cells
  22. Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study
    Warren H. Capell, Elliot S. Barnathan, Gregory Piazza, Alex C. Spyropoulos, Judith A. Hsia, Scott A. Bull, Concetta Lipardi, Chiara Sugarmann, Eunyoung Suh, Jaya Prakash Rao et al. · 2021 · American Heart Journal
  23. Children and young adults hospitalized for severe COVID‐19 exhibit thrombotic coagulopathy
    William Beau Mitchell, Jennifer G. Davila, Janine Keenan, Jenai Jackson, Adit L. Tal, Kerry A. Morrone, Ellen Johnson Silver, Sarah H. O’Brien, Deepa G. Manwani · 2021 · Pediatric Blood & Cancer
  24. Tissue factor upregulation is associated with SARS‐CoV‐2 in the lungs of COVID‐19 patients
    SANDEEP MOOTHEDATH SUBRAHMANIAN, Alain Borczuk, Steven Salvatore, Kar‐Ming Fung, Joan T. Merrill, Jeffrey C. Laurence, Jasimuddin Ahamed · 2021 · Journal of Thrombosis and Haemostasis
  25. COVID-19 and cardiovascular disease: manifestations, pathophysiology, vaccination, and long-term implication
    Adel Abdel‐Moneim, Marwa A. Radwan, Ahmed I. Yousef · 2022 · Current Medical Research and Opinion
  26. Transcriptional reprogramming from innate immune functions to a pro-thrombotic signature by monocytes in COVID-19
    Allison K. Maher, Katie L. Burnham, Emma M. Jones, Michelle MH Tan, Rocel Christine Saputil, Laury Baillon, Claudia Selck, Nicolas Giang, Rafael José Argüello, Clio Pillay et al. · 2022 · Nature Communications
  27. Acute and Post-Acute COVID-19 Cardiovascular Complications: A Comprehensive Review
    Christo Kole, Εleni Stefanou, Nikolaos Karvelas, Dimitriοs Schizas, Konstantinos P. Toutouzas · 2023 · Cardiovascular Drugs and Therapy
  28. “COVID-19 and cervical artery dissection- A causative association?”
    Pratit D. Patel, Priyank Khandelwal, Gaurav Gupta, Amit Singla · 2020 · Journal of Stroke and Cerebrovascular Diseases
  29. Coronavirus disease 2019 (COVID-19) and immune-mediated inflammatory rheumatic diseases: at the crossroads of thromboinflammation and autoimmunity
    Evgeny Lvovich Nasonov, Tatiana Valentinovna Beketova, Tatiana Magomedalievna Reshetnyak, Aleksander M. Lila, L. Ananieva, Tatyana Andreyevna Lisitsyna, S. K. Soloviev · 2020 · Rheumatology Science and Practice
  30. Emerging Neurological and Psychobiological Aspects of COVID-19 Infection
    Lyubka P. Tancheva, Maria Cristina Petralia, Simona Miteva, Stela Dragomanova, Ayten Solak, Reni E. Kalfin, Maria I. Lazarova, Dobri Yarkov, Rosella Ciurleo, Eugenio Cavalli et al. · 2020 · Brain Sciences
  31. Design and rationale of the COVID-19 Critical Care Consortium international, multicentre, observational study
    Gianluigi Li Bassi, Jacky Yung Suen, Adrian Gerard Barnett, Amanda Corley, Jonathan Edward Millar, Jonathon Paul Fanning, India Lye, Sebastiano Maria Colombo, Karin S. Wildi, Samantha Livingstone et al. · 2020 · BMJ Open
  32. Understanding COVID-19 Pandemic: Molecular Mechanisms and Potential Therapeutic Strategies. An Evidence-Based Review
    Reem Hanna, Snehal Dalvi, Tudor Sălăgean, Ioana Pop, Ioana Roxana Bordea, Stefano Benedicenti · 2021 · Journal of Inflammation Research
  33. Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps
    Brandon Bautista-Becerril, Rebeca Campi-Caballero, Samuel Sevilla-Fuentes, Laura M. Hernández-Regino, Alejandro Hanono, Al Flores-Bustamante, Julieta González-Flores, Carlos Alberto García-Ávila, Arnoldo Aquino‐Gálvez, Manuel de Jesús Castillejos-López et al. · 2021 · Biomolecules
  34. Immuno-Thrombotic Complications of COVID-19: Implications for Timing of Surgery and Anticoagulation
    Connor M. Bunch, Ernest Eugene Moore, Hunter B. Moore, Matthew D. Neal, Anthony V. Thomas, Nuha Zackariya, Jonathan C. Zhao, Sufyan K. Zackariya, Toby J. Brenner, Margaret Berquist et al. · 2022 · Frontiers in Surgery
  35. Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting - A report of 4 cases
    Siri Øverstad, Eirik Brekka Tjønnfjord, Lamya Garabet, Synne Gronvold Fronas, Jonas Bergan, Saad Aballi, Waleed Ghanima · 2020 · Thrombosis Research
  36. Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2
    Lucia Lisi, Pedro Miguel Lacal, Maria Luisa Barbaccia, Grazia Graziani · 2020 · Biochemical Pharmacology
  37. Preparedness and Reorganization of Care for Coronavirus Disease 2019 Patients in a Swiss ICU: Characteristics and Outcomes of 129 Patients
    Steve Primmaz, Christophe Le Terrier, Noémie Suh, François Ventura, Filippo Boroli, Karim Bendjelid, Sara Cereghetti, Raphaël Giraud, Claudia Paula Heidegger, Déborah Pugin et al. · 2020 · Critical Care Explorations
  38. Collaborating Across Private, Public, Community, and Federal Hospital Systems: Lessons Learned from the Covid-19 Pandemic Response in NYC
    Verity E. Schaye, Jenna A. Reich, Brian P. Bosworth, David Thomas Stern, Frank Volpicelli, N Shapiro, Kevin D. Hauck, Ian Fagan, Seagram M. Villagomez, Amit Uppal et al. · 2020 · NEJM Catalyst
  39. COVID-19 and Acute Coronary Syndromes: Current Data and Future Implications
    Matteo Cameli, Maria Concetta Pastore, Giulia Elena Mandoli, Flavio D’Ascenzi, Marta Focardi, Giulia Biagioni, Paolo Cameli, Giuseppe Patti, Federico Franchi, Sergio Mondillo et al. · 2021 · Frontiers in Cardiovascular Medicine
  40. Effects of SARS-CoV-2 Inflammation on Selected Organ Systems of the Human Body
    Marta Kopańska, Edyta Barnaś, Joanna Błajda, Barbara Kuduk, Anna Łagowska, Agnieszka Banaś-Ząbczyk · 2022 · International Journal of Molecular Sciences
  41. COVID-19 disease and autoimmune disorders: A mutual pathway
    Mohammed Al‐Beltagi, Nermin Kamal Saeed, Adel Salah Bediwy · 2022 · World Journal of Methodology
  42. COVID-19: Diabetes Perspective—Pathophysiology and Management
    Siva Dallavalasa, SubbaRao V. Tulimilli, Prakash Janhavi, Ramya Ramachandra, SubbaRao V. Madhunapantula, Ravindra P. Veeranna · 2023 · Pathogens
  43. COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance
    Suzanne C. Cannegieter, Frederikus Albertus Klok · 2020 · Research and Practice in Thrombosis and Haemostasis
  44. Recommendations of the Thoracic Imaging Section of the German Radiological Society for clinical application of chest imaging and structured CT reporting in the COVID-19 pandemic
    Jens Vogel‐Claussen, Julia Ley‐Zaporozhan, Prerana Agarwal, Jürgen Biederer, Hans‐Ulrich Kauczor, Sebastian Ley, Hilmar Kühl, Ullrich G. Müeller-Lisse, Thorsten Persigehl, Christopher L. Schlett et al. · 2020 · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
  45. Antithrombotic Therapies in COVID-19 Disease: a Systematic Review
    Edward B. Maldonado, Derrick Law Tao, Katherine Mackey · 2020 · Journal of General Internal Medicine
  46. Structured reporting of chest CT in COVID-19 pneumonia: a consensus proposal
    Emanuele Neri, Francesca Coppola, Anna Rita Larici, Nicola Sverzellati, Maria Antonietta Mazzei, Palmino Sacco, Giorgia Dalpiaz, Beatrice Feragalli, Vittorio Miele, Roberta Grassi · 2020 · Insights into Imaging
  47. Relationship of D‐dimer with severity and mortality in SARS‐CoV‐2 patients : A meta‐analysis
    Johanes Nugroho, Ardyan Prima Wardhana, Irma Maghfirah, Eka Prasetya Budi Mulia, Dita Aulia Rachmi, Maya Qurota A’yun, Imanita Septianda · 2020 · International Journal of Laboratory Hematology
  48. Mechanisms of COVID‐19‐induced cardiovascular disease: Is sepsis or exosome the missing link?
    Mallikarjun Patil, Sarojini Singh, John Henderson, Prasanna Krishnamurthy · 2020 · Journal of Cellular Physiology
  49. The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System
    Georgina M. Ellison, Liam Sean Colley, Katie A. O’Brien, Kirsty A. Roberts, Thomas A. Agbaedeng, Mark Ross · 2020 · Frontiers in Cardiovascular Medicine
  50. Real‐World Evidence for Assessing Pharmaceutical Treatments in the Context of COVID‐19
    Jessica Myers Franklin, Kueiyu Joshua Lin, Nicolle M. Gatto, Jeremy A. Rassen, Robert J. Glynn, Sebastian Schneeweiß · 2021 · Clinical Pharmacology & Therapeutics
  51. Clinical Significance of Plasma D-Dimer in COVID-19 Mortality
    LI Yayun, Yuhao Deng, Lin Ye, Huiyan Sun, Songtao Du, Huining Huang, Furong Zeng, Xiang Chen, Guangtong Deng · 2021 · Frontiers in Medicine
  52. Emergency Nursing Care of Patients With Novel Coronavirus Disease 2019
    Katie Deitrick, Jourdan Adams, Joshua J. Davis · 2020 · Journal of Emergency Nursing
  53. Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients
    Dominik J. Hoechter, Andrea Becker-Pennrich, J. Langrehr, Mathias Bruegel, Bernhard Zwißler, Simon Schaefer, M. Spannagl, Ludwig Christian Hinske, Michael Zöller · 2020 · Thrombosis Research
  54. COVID-19, Antiphospholipid Antibodies, and Catastrophic Antiphospholipid Syndrome: A Possible Association?
    Georges El Hasbani, Ali T. Taher, Ali S. Jawad, Imad W. Uthman · 2020 · Clinical Medicine Insights Arthritis and Musculoskeletal Disorders
  55. Acute Limb Ischemia in a Peruvian Cohort Infected by COVID-19
    Juan Bautista Sánchez, Juan Diego Cuipal Alcalde, Rossi Ramos-Isidro, Carlos Zuñiga Luna, W Samir Cubas, André Coaguila Charres, José Egoávil Gutiérrez, Juan David Ochoa, Patricia Fernández Arias · 2020 · Annals of Vascular Surgery
  56. D-Dimer-Driven Anticoagulation Reduces Mortality in Intubated COVID-19 Patients: A Cohort Study With a Propensity-Matched Analysis
    Apostolos K. Tassiopoulos, Sima Mofakham, Jerry A. Rubano, Nicos Labropoulos, Mohsen Bannazadeh, Panagiotis Drakos, Panagiotis Volteas, Nathaniel A. Cleri, Leor N. Alkadaa, Anthony A. Asencio et al. · 2021 · Frontiers in Medicine
  57. Neuropsychology of COVID-19: Anticipated cognitive and mental health outcomes.
    Erin K. Bailey, Kayla A. Steward, Alicia B. VandenBussche Jantz, Joel E. Kamper, Elaine J. Mahoney, Jennifer J. Duchnick · 2021 · Neuropsychology
  58. Prediction of venous thromboembolism with machine learning techniques in young-middle-aged inpatients
    Hua Liu, Hua Yuan, Yongmei Wang, Weiwei Huang, Hui Xue, Xiuying Zhang · 2021 · Scientific Reports
  59. SARS‐CoV‐2 infection induces soluble platelet activation markers and PAI‐1 in the early moderate stage of COVID‐19
    Abaher O. Al‐Tamimi, Ayesha M. Yusuf, Manju Nidagodu Jayakumar, Abdul Wahid Ansari, Mona Elhassan, Fatema Abdulkarim, Meganathan Kannan, Rabih Halwani, Firdos Ahmad · 2022 · International Journal of Laboratory Hematology
  60. COVID-19 related thrombosis: A mini-review
    Nicole M Cheng, Yiu Che Chan, Stephen W.K. Cheng · 2022 · Phlebology The Journal of Venous Disease
  61. Abnormal concentration of porphyrins in serum from COVID‐19 patients
    Itxaso San Juan, Chiara Bruzzone, Maider Bizkarguenaga, Ganeko Bernardo‐Seisdedos, Ana Laín, Rubén Gil‐Redondo, Tammo Diercks, Jon Gil‐Martínez, Pedro Urquiza, Eunate Arana‐Arri et al. · 2020 · British Journal of Haematology
  62. Imaging Volume Trends and Recovery During the COVID-19 Pandemic: A Comparative Analysis Between a Large Urban Academic Hospital and Its Affiliated Imaging Centers
    Min Lang, Tristan Yeung, Dexter P. Mendoza, Efrén J. Flores, Avik Som, Angela Lu Lang, Oleg S. Pianykh, Susanna I. Lee, Sanjay Saini, Brent P. Little et al. · 2020 · Academic Radiology
  63. Coronavirus Historical Perspective, Disease Mechanisms, and Clinical Outcomes
    Sean Pinney, Gennaro Giustino, Jonathan L. Halperin, Jeffrey Ian Mechanick, Eric Neibart, Jeffrey W. Olin, Robert S. Rosenson, Valentı́n Fuster · 2020 · Journal of the American College of Cardiology
  64. Mortality of COVID-19 patients with vascular thrombotic complications
    J.A. González-Fajardo, Marina Ansuátegui, Carmen Romero, A. Comanges Yéboles, Diego Gómez-Arbeláez, Gabriela Zambrano Ibarra, Ania Garcia-Gutierrez · 2020 · Medicina Clínica (English Edition)
  65. Incidence, prognostic factors, and outcomes of venous thromboembolism in critically ill patients: data from two prospective cohort studies
    Ruben Julius Eck, Lisa Hulshof, Renske Wiersema, Chris H. L. Thio, Bart Hiemstra, Niels C. Gritters van den Oever, Rijk O. B. Gans, Iwan C.C. van der Horst, Karina Meijer, Frederik Keus · 2021 · Critical Care
  66. Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients
    Colin Pawlowski, AJ Venkatakrishnan, Christian Kirkup, Gabriela Berner, Arjun Puranik, John Charles O’Horo, Andrew D. Badley, Venky Soundararajan · 2021 · EClinicalMedicine
  67. COVID-19 in People With Schizophrenia: Potential Mechanisms Linking Schizophrenia to Poor Prognosis
    Mohapradeep Mohan, Benjamin Ian Perry, Ponnusamy Saravanan, Swaran Preet Singh · 2021 · Frontiers in Psychiatry
  68. Platelet Activation and Thrombosis in COVID-19
    Toshiaki Iba, Hideo Wada, Jerrold H. Levy · 2022 · Seminars in Thrombosis and Hemostasis
  69. How the COVID-19 pandemic highlights the necessity of animal research
    Lisa Genzel, Roger A.H. Adan, Anton J. M. Berns, Jeroen J.J.P. van den Beucken, Arjan Blokland, Erik Boddeke, Willy M J M Bogers, Ronald E. Bontrop, Roos Bulthuis, Teun Bousema et al. · 2020 · Current Biology
  70. Priapism in a patient with coronavirus disease 2019 (COVID-19)
    Myriam Lamamri, A. Chebbi, Jordan Mamane, Sofia Abbad, Milena Munuzzolini, Florence Sarfati, Stéphane Legriel · 2020 · The American Journal of Emergency Medicine
  71. Aortic thrombus in patients with severe COVID-19: review of three cases
    María de Carranza, D. Salazar-Chiriboga, Jesús Troya, Roberto Alcázar Arroyo, Cristina Peña, Esther Aragón, Marta Domínguez, Juan Torres‐Macho, Nuria Muñoz‐Rivas · 2020 · Journal of Thrombosis and Thrombolysis
  72. Evidence of a wide gap between COVID-19 in humans and animal models: a systematic review
    Salleh N. Ehaideb, Mashan L. Abdullah, Bisher Abuyassin, Abderrezak Bouchama · 2020 · Critical Care
  73. Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants
    Osamu Kumano, Kohei Akatsuchi, Jean Amiral · 2021 · Biomedicines
  74. Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?
    Thomas Foret, Virginie Dufrost, Lucie Salomon du Mont, Patrícia Costa, Benjamin Lefèvre, Patrick J. Lacolley, Véronique Regnault, Stéphane Zuily, Denis G. Wahl · 2021 · Current Rheumatology Reports
  75. COVID‐19 and coagulopathy
    Malay S. Sarkar, Irappa Madabhavi, Pham Nguyen Quy, Manjunath B Govindagoudar · 2021 · The Clinical Respiratory Journal
  76. An overview on in vitro and in vivo antiviral activity of lactoferrin: its efficacy against SARS-CoV-2 infection
    Luigi Rosa, Antimo Cutone, Maria Pia Conte, Elena Campione, Luca Bianchi, Piera Valenti · 2022 · BioMetals
  77. Pathogenesis and Mechanisms of SARS-CoV-2 Infection in the Intestine, Liver, and Pancreas
    Zaid Khreefa, Mallory T. Barbier, Ali Rıza Köksal, Gordon L. Love, Luis Del Valle · 2023 · Cells
  78. Micronutrients throughout the Life Cycle: Needs and Functions in Health and Disease
    Mohit Kumar, Devesh Kumar, Ankita Sharma, Shivam Bhadauria, Anil Thakur, Amit Bhatia · 2023 · Current Nutrition & Food Science
  79. Rescue therapy for severe COVID-19–associated acute respiratory distress syndrome with tissue plasminogen activator: A case series
    Christopher D. Barrett, Achikam Oren-Grinberg, Edward Chao, Andrew H. Moraco, Matthew J. Martin, Srinivas H. Reddy, Annette M. Ilg, Rashi Jhunjhunwala, Marco Uribe, Hunter B. Moore et al. · 2020 · The Journal of Trauma: Injury, Infection, and Critical Care
  80. Update on the neurology of COVID‐19
    Josef Finsterer, Claudia Stöllberger · 2020 · Journal of Medical Virology
  81. Renal infarct in a COVID-19–positive kidney–pancreas transplant recipient
    Jieqing J. Xu, Daniel Samaha, Suhas Mondhe, David Massicotte‐Azarniouch, Greg A. Knoll, Marcel Ruzicka · 2020 · American Journal of Transplantation
  82. Ventilation/perfusion SPECT/CT findings in different lung lesions associated with COVID-19: a case series
    Nina Cobes, Mohamed Guernou, David Lussato, Mathieu Queneau, Bernard Songy, G. Bonardel, Jean-François Grellier · 2020 · European Journal of Nuclear Medicine and Molecular Imaging
  83. Microglia Fighting for Neurological and Mental Health: On the Central Nervous System Frontline of COVID-19 Pandemic
    Elisa Gonçalves de Andrade, Eva Šimončičová, Micaël Carrier, Haley A. Vecchiarelli, Marie-Ève Robert, Marie‐Ève Tremblay · 2021 · Frontiers in Cellular Neuroscience
  84. Acute pulmonary hypertension and short‐term outcomes in severe Covid‐19 patients needing intensive care
    Joakim Norderfeldt, Andreas Liliequist, CLAES G. FROSTELL, Christofer Adding, Per Agvald, Maria J. Eriksson, Per‐Arne Lönnqvist · 2021 · Acta Anaesthesiologica Scandinavica
  85. Heparin-Functionalized Adsorbents Eliminate Central Effectors of Immunothrombosis, including Platelet Factor 4, High-Mobility Group Box 1 Protein and Histones
    Marie Ebeyer-Masotta, Tanja Eichhorn, René Weiss, Vladislav Semak, Lucia Lauková, Michael Bernhard Fischer, Viktoria Weber · 2022 · International Journal of Molecular Sciences
  86. Thrombosis and Coagulopathy in COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation
    Hakeem O. Yusuff, Vasileios Zochios, Daniel Brodie · 2020 · ASAIO Journal
  87. SARS-CoV-2 Receptors are Expressed on Human Platelets and the Effect of Aspirin on Clinical Outcomes in COVID-19 Patients
    Aditya Sahai, Rohan Bhandari, Milka Koupenova, Jane E. Freedman, Mathew Godwin, Thomas M. McIntyre, Mina K. Chung, Jean‐Pierre Iskandar, Hayaan Kamran, Anu Aggarwal et al. · 2020
  88. Prehabilitation may help mitigate an increase in COVID-19 peripandemic surgical morbidity and mortality
    Silver, Julie K. · 2020 · American Journal of Physical Medicine & Rehabilitation
  89. Neurological emergencies associated with COVID-19: stroke and beyond
    Amit Kumar Agarwal, Marco C. Pinho, Karuna M. Raj, Frank F. Yu, Girish Bathla, Michael Achilleos, Thomas J. O’Neill, Michael Still, Joseph A. Maldjian · 2020 · Emergency Radiology
  90. Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
    Nicola Giesen, Rosanne Sprute, Maria Madeleine Rüthrich, Yascha Khodamoradi, Sibylle C. Mellinghoff, Gernot Beutel, Catherina Lueck, Michael Koldehoff, Marcus Hentrich, Michael Sandherr et al. · 2020 · European Journal of Cancer
  91. Strategies to DAMPen COVID-19-mediated lung and systemic inflammation and vascular injury
    Christian Bime, Nancy G. Casanova, Janko Nikolich‐Žugich, Kenneth S. Knox, Sara M. Camp, Joe G. N. Garcia · 2020 · Translational research
  92. Intracerebral Hemorrhage in COVID-19 Patients with Pulmonary Failure: A Propensity Score-Matched Registry Study
    Corinna N. Lang, Johanna S. Dettinger, Michael Berchtold‐Herz, Stefan Utzolino, Xavier Bemtgen, Viviane Zotzmann, Bonaventura Schmid, Paul Marc Biever, Christoph Bode, Katharina Müller‐Peltzer et al. · 2021 · Neurocritical Care
  93. The Weight of Obesity in Immunity from Influenza to COVID-19
    Fernanda Brandi Andrade, Ana Cristina Moura Gualberto, CAMILA PEREIRA DE REZENDE, Nathércia Percegoni, Jacy Gameiro, Eugênio Damaceno Hottz · 2021 · Frontiers in Cellular and Infection Microbiology
  94. Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses
    Christopher A. Beaudoin, Arian R. Jamasb, Ali F. Alsulami, Liviu Copoiu, Andries J. van Tonder, Sharif M. Hala, Bridget P. Bannerman, S.E. Thomas, Sundeep Chaitanya Vedithi, Pedro Henrique Monteiro Torres et al. · 2021 · Computational and Structural Biotechnology Journal
  95. Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathy
    Rossella Rosaria Cacciola, Elio Gentilini Cacciola, Veronica Vecchio, Emma Cacciola · 2021 · Journal of Thrombosis and Thrombolysis
  96. An Integrated Radiologic-Pathologic Understanding of COVID-19 Pneumonia
    Jong Hyuk Lee, Jaemoon Koh, Yoon Kyung Jeon, Jin Mo Goo, Soon Ho Yoon · 2023 · Radiology
  97. Abdominal Visceral Infarction in 3 Patients with COVID-19
    Giulia Besutti, Riccardo Bonacini, Valentina Iotti, Giulia Maria Francesca Marini, Nicoletta Riva, Giovanni Dolci, Mariarosa Maiorana, Lucia Spaggiari, Filippo Monelli, Guido Ligabue et al. · 2020 · Emerging infectious diseases
  98. COVID-19 Presented With Deep Vein Thrombosis: An Unusual Presenting
    Lotfollah Davoodi, Hamed Jafarpour, Morteza Taghavi, Alireza Razavi · 2020 · Journal of Investigative Medicine High Impact Case Reports
  99. Pulmonary embolism: A complication of COVID 19 infection
    Tamer Akel, Firas Qaqa, Ahmad Abuarqoub, Fayez E. Shamoon · 2020 · Thrombosis Research
  100. Systematic Screening for Venous Thromboembolic Events in COVID-19 Pneumonia
    Gaël Grandmaison, Antoine Andrey, Daniel Périard, Rolf Peter Engelberger, Guillaume Carrel, Sébastien Doll, Jean-Baptiste Dexpert, Caroline Krieger, Hatem Ksouri, Daniel Hayoz et al. · 2020 · TH Open